He has over 15 years of professional experience specializing in clinical immunological testing. His core expertise centers on the clinical detection and clinical application of serum tumor markers for malignant tumors. He is currently affiliated with the Clinical Laboratory of Sun Yat-sen University Cancer Center, dedicated to translating laboratory testing technologies into reliable auxiliary indicators for tumor early identification and prognosis monitoring.

1. Lingyun Li , Zhongyun Lan , Huarui Qiao , Xiangjing Meng , Ziyang Shi , Wanting Zhang , Yi'ang Wang , Zengchao Sun , Qianqian Cui , Lu Wang , Siyu Zhou , Fangzheng Hu , Daizhou Zhang , Yuanyuan Dai , Hao Chen , Yong Geng. Design of NanoBiT-Nanobody-based FGL1 biosensors for early assisted diagnosis of esophageal cancer. Biomaterials,. 2025 ,320:123286.

2. Te Liang; Hao Chen; Lei Liu; Yongqiang Zheng; Zhaoen Ma; Ling Min; Jiahui Zhang; Lianfu Wu; Jie Ma; Zexian Liu; Qingfeng Zhang; Kai Luo; Di Hu; Tianxing Ji; Xiaobo Yu ; Antibody profiling of pan-cancer viral proteome reveals biomarkers for nasopharyngeal carcinoma diagnosis and prognosis, Molecular Cellular Proteomics, 2024, 23(3) 

3. Nansong Xu, Changchun Lai, Qing-Mei He, Yubo Cai, Hui Yu, Wenhao Zhong, Shulin Chen, Fang-Cai Wu, Hao Chen. Integrated proteomics and phosphoproteomics analyses of esophageal cancer cells with different invasive abilities. Life Sciences. 2023, 1:332:122078. doi: 10.1016/j.lfs.2023.122078

4. Ao Zhang , Guanqing Zhong, Luocan Wang, Rongzeng Cai, Runkun Han, Caixia Xu, Shulin Chen, Peng Sun, Hao Chen. Dynamic serum biomarkers to predict the efficacy of PD-1 in patients with nasopharyngeal carcinoma. Cancer Cell Int. 2021 Sep 28;21(1):518. doi: 10.1186/s12935-021-02217-y.